Improving health and social care through evidence-based guidance

Latest guidance

COVID-19 rapid guideline: delivery of systemic anticancer treatments
Human and animal bites: antimicrobial prescribing
Dexcom G6 for real-time continuous glucose monitoring
ClearGuard HD Antimicrobial Barrier Cap for preventing haemodialysis catheter-related bloodstream infections
KardiaMobile for the ambulatory detection of atrial fibrillation

Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management
Midostaurin for treating advanced systemic mastocytosis ID1573
Stroke rehabilitation in adults
Nivolumab for adjuvant treatment of completely resected melanoma with lymph node involvement or metastatic disease (CDF Review of TA558) [ID1681]
Nivolumab for previously treated unresectable advanced oesophageal cancer [ID1249]

NICE recommends new chemotherapy-free treatment option for people with untreated chronic lymphocytic leukaemia
NICE draft guidance addresses the continuing debate about the best approach to the diagnosis and management of ME/CFS
NICE to become single point of access for Covid-19 guidance and advice
NICEвЂ™s methods of technology evaluation - presenting a case for change